Highly oxygenated ent-abietane diterpenoid lactones from Euphorbia peplus and their anti-inflammatory activity
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2024.107989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Ying Yan und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants & College of Pharmacy, Guizhou Provincial Engineering Technology Research Cent…. Hauptthemen laut MEDLINE: Euphorbia, Abietanes, Nitric Oxide, Lipopolysaccharides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Eleven new ent-abietane diterpenoid lactones, designated euphjatrophanes H-R (1-11), were isolated from the whole plants of Euphorbia peplus, along with nine previously identified congeners (12-20). Their structures, including absolute configurations, were elucidated through a combination of NMR, HRESIMS, single-crystal X-ray diffraction, and calculations of ECD and DP4 + technologies. Notably, the absolute configurations of six compounds 1, 2, 4, 5, 6, and 7 were unambiguously determined by single-crystal X-ray diffraction analyses, conducted with Cu Kα radiation. The anti-inflammatory potential of all ent-abietane diterpenoid lactones was evaluated on macrophages. Compounds 6-9, 12-16 and 19 significantly suppressed nitric oxide production, while 10 μM of compounds 6, 9, 11 and 16 remarkably suppressed the mRNA expression of IL-6, IL-1β, and TNFα in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. Notably, compound 6 demonstrated a dose-dependent inhibition of the levels of inflammatory mediators (IL-6, IL-1β, and TNFα). Furthermore, compound 6 effectively suppressed FOXO1 expression and reduced the phosphorylation level of NF-κB p65. These findings suggest that compound 6 might be a promising candidate for treating inflammation-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Functions and Applications of Medicinal Plants & College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang 550014,…
- Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for Translational Cancer Research of Chinese Medicine, Inte…
- Academy of Biomedical Engineering, Kunming Medical University, Kunming 650500, Yunnan, China.
- Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, China. Electronic address: qinxujie@mail.kib.ac.cn.
- Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, China. Electronic address: diyt@mail.kib.ac.cn.
- Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, China.
Zitieren
APA
Yan, Y., Peng, M. Y., Yang, Y., Zhang, Z. B., Zhang, L. L., Tang, L., Qin, X. J., Cheng, Y. Y., Di, Y. T., & Hao, X. J. (2025). Highly oxygenated ent-abietane diterpenoid lactones from Euphorbia peplus and their anti-inflammatory activity. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2024.107989
Vancouver
Yan Y, Peng MY, Yang Y, Zhang ZB, Zhang LL, Tang L, et al. Highly oxygenated ent-abietane diterpenoid lactones from Euphorbia peplus and their anti-inflammatory activity. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2024.107989
BibTeX
@article{Yan2025,
author = {Yan, Ying and Peng, Ming-You and Yang, Ying and Zhang, Zhi-Bi and Zhang, Long-Long and Tang, Lei and Qin, Xu-Jie and Cheng, Yuan-Yuan and Di, Ying-Tong and Hao, Xiao-Jiang},
title = {Highly oxygenated ent-abietane diterpenoid lactones from Euphorbia peplus and their anti-inflammatory activity},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2024.107989}
}
EUVIMED